Bluebird bio Inc (NASDAQ: BLUE) kicked off on Friday, down -11.53% from the previous trading day, before settling in for the closing price of $0.36. Over the past 52 weeks, BLUE has traded in a range of $0.34-$5.53.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 120.02% over the past five years. While this was happening, its average annual earnings per share was recorded 21.51%. With a float of $192.72 million, this company’s outstanding shares have now reached $192.77 million.
Let’s look at the performance matrix of the company that is accounted for 375 employees. In terms of profitability, gross margin is -43.49%, operating margin of -596.15%, and the pretax margin is -565.89%.
Bluebird bio Inc (BLUE) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Bluebird bio Inc is 0.89%, while institutional ownership is 34.22%. The most recent insider transaction that took place on Sep 30 ’24, was worth 529. In this transaction an insider of this company sold 1,006 shares at a rate of $0.53, taking the stock ownership to the 170,000 shares. Before that another transaction happened on Sep 30 ’24, when Company’s President and CEO sold 34,780 for $0.53, making the entire transaction worth $18,270. This insider now owns 375,218 shares in total.
Bluebird bio Inc (BLUE) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.78 earnings per share (EPS), lower than consensus estimate (set at -0.56) by -0.22. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.18 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 21.51% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 45.80% during the next five years compared to 28.98% growth over the previous five years of trading.
Bluebird bio Inc (NASDAQ: BLUE) Trading Performance Indicators
Take a look at Bluebird bio Inc’s (BLUE) current performance indicators. Last quarter, stock had a quick ratio of 0.33. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.04.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.80, a number that is poised to hit -0.29 in the next quarter and is forecasted to reach -0.52 in one year’s time.
Technical Analysis of Bluebird bio Inc (BLUE)
Bluebird bio Inc (NASDAQ: BLUE) saw its 5-day average volume 6.42 million, a negative change from its year-to-date volume of 7.44 million. As of the previous 9 days, the stock’s Stochastic %D was 14.93%. Additionally, its Average True Range was 0.04.
During the past 100 days, Bluebird bio Inc’s (BLUE) raw stochastic average was set at 0.17%, which indicates a significant decrease from 0.99% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 74.64% in the past 14 days, which was lower than the 95.55% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4857, while its 200-day Moving Average is $0.9107. Nevertheless, the first resistance level for the watch stands at $0.3542 in the near term. At $0.3875, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.4052. If the price goes on to break the first support level at $0.3032, it is likely to go to the next support level at $0.2855. Assuming the price breaks the second support level, the third support level stands at $0.2522.
Bluebird bio Inc (NASDAQ: BLUE) Key Stats
The company with the Market Capitalisation of 55.19 million has total of 193,914K Shares Outstanding. Its annual sales at the moment are 29,500 K in contrast with the sum of -211,910 K annual income. Company’s last quarter sales were recorded 16,100 K and last quarter income was -81,390 K.
